Wiesbaden, Germany

Korden Walter

USPTO Granted Patents = 18 

 

 

Average Co-Inventor Count = 7.0

ph-index = 4

Forward Citations = 58(Granted Patents)


Location History:

  • Mainz, DE (2020 - 2023)
  • Wiesbaden, DE (2016 - 2024)
  • Saulheim, DE (2022 - 2024)

Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: **Innovator Spotlight: Korden Walter**

Introduction

Korden Walter, an accomplished inventor based in Wiesbaden, Germany, has made significant contributions to the field of biotechnology with a focus on cancer research. With an impressive portfolio of 18 patents, his work primarily revolves around the development of innovative antibodies for cancer diagnosis and treatment.

Latest Patents

Among his latest patents, Korden has developed pioneering antibodies that are essential for cancer diagnosis. One such invention involves antibodies directed against an epitope in the C-terminal portion of CLDN6, which are instrumental in diagnosing cancer and assessing whether cancer cells express CLDN6. Additionally, he has created antibodies that serve as therapeutics for various diseases associated with cells expressing CLDN6. These antibodies target a range of tumor-related diseases, including but not limited to ovarian cancer, lung cancer, gastric cancer, breast cancer, hepatic cancer, pancreatic cancer, skin cancer, malignant melanoma, head and neck cancer, sarcoma bile duct cancer, urinary bladder cancer, kidney cancer, colon cancer, placental choriocarcinoma, cervical cancer, testicular cancer, and uterine cancer.

Career Highlights

Throughout his career, Korden Walter has held positions at prominent institutions and companies, including Johannes Gutenberg University Mainz and Ganymed Pharmaceuticals GmbH. His research and development efforts at these organizations have significantly advanced the understanding and treatment of various cancers, showcasing his dedication to combating this pervasive disease.

Collaborations

Korden has collaborated with notable figures in the field, such as Ugur Sahin and Maria Kreuzberg. These partnerships have allowed him to leverage collective expertise to push the boundaries of cancer research and enhance the efficacy of new therapeutic approaches.

Conclusion

Korden Walter’s innovative work in developing diagnostic and therapeutic antibodies marks him as a key player in the fight against cancer. His extensive patent portfolio not only reflects his creativity and technical skills but also underscores the importance of collaborative efforts in advancing scientific knowledge. As research continues to evolve, Korden’s contributions will undoubtedly have a lasting impact on cancer diagnostics and treatment strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…